Objective
Affecting 1 in 500 individuals; Hypertrophic cardiomyopathy (HCM) is an
autosomal dominant cardiovascular disorder which is prevalent throughout
the world. Surgical myectomy and alcohol septal ablation (ASA) are two
methods currently used for the management of drug refractory
Hypertrophic obstructive cardiomyopathy (HOCM). ASA may prove to be a
useful, less invasive tool when confronting patients with HOCM
especially those who are more elderly or deemed to be a higher surgical
risk.